PLASMACHEM

PlasmaChem's main business field concerns with nano-materials, detonation-, vacuum-, plasma- and ultra-thin film technologies and their biomedical and technical applications. From 1998 PlasmaChem GmbH began manufacturing new patented cardio-implants (BioDiamond) of unique design and properties, with biocompatible nano-layered Diamond-Like Carbon (DLC)-coating which serves as an effective barrier against leakage of heavy metal ions (i.e. Cr, Ni, Mo) from surgical stainless steel 316L. Furthermo... re PlasmaChem has developed new generations of cardio-surgical implants - implants with controlled drug elution and biosoluble (biodegradable) temporary implants. In the area of medical devices PlasmaChem GmbH has developed also leading-edge contact lenses of long wear (> 90 days/nights permanent usage). In 2004 a new company was founded in cooperation with Bayer AG, Germany (Leverkusen) for manufacturing and promotion of these products. This company — Lenswista AG — is now located in Berlin/Adlershof too. Plasmachem performs chemical and low temperature plasma modification of nanopowders with the purpose of functionalization of nano-particle's surface assisted by new plasma-chemical methods developed by PlasmaChem for ultra-dispersed materials. This approach leads to a new family of industrial nano-products with improved and tailor-made properties. PlasmaChem GmbH developed a novel and unique surface analysis method — NanoLuminography. The R&D phase has been completed, several patent applications were filed and granted already at national phase. A first commercial prototype is recently in progress.More